46.46.Z - Wholesale trade of pharmaceutical and medical products
21.10.Z - Manufacture of basic pharmaceutical products
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.45.Z - Wholesale trade of perfumes and cosmetics
46.90.Z - Non-specialized wholesale trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
73.1 - Advertising
73.2 - Market research and public opinion polling
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -2,1 | -3,3 | -2,3 | 30 |
Gross profit (loss) | -2,1 | -3,3 | -2,4 | 28,1 |
EBITDA | -2,1 | -3,3 | -2,3 | 30,1 |
Short time liabilities | 19,6 | 18,5 | 17,4 | -6 |
Other operating costs | 0 | 0 | 0 | -90,6 |
Equity capital | -2,3 | -5,6 | -8 | -43 |
Operating profit (EBIT) | -2,1 | -3,3 | -2,3 | 30,1 |
Assets | 17,4 | 16,9 | 13,4 | -20,8 |
Net profit (loss) | -2,1 | -3,3 | -2,4 | 28,1 |
Cash | 8,9 | 7,5 | 12,9 | 72,2 |
Net income from sale | 0 | 0 | 0,2 | -∞ |
Liabilities and provisions for liabilities | 19,6 | 22,5 | 21,4 | -4,9 |
Working assets | 17,4 | 16,7 | 13,2 | -21,1 |
Other income costs | 0 | 0 | 0 | -93,8 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 91,6 | 59,8 | 30,1 | -29,7 |
Equity capital to total assets | -13 | -33,2 | -59,9 | -26,7 |
Gross profit margin | -1204,3 | |||
EBITDA Margin | -1170,6 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 31 722 | -2 147 451 926 |
Current financial liquidity indicator | 0.8851615786552429 | 0.9026042222976685 | 0.7578328251838684 | -0,1 |
Net dept to EBITDA | 4.319815635681152 | 1.0492992401123047 | 3.8179781436920166 | 2,8 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane